Table 3.
Comparison of paraclinical characteristics for the patients included in the analyzed subgroups.
| Paraclinical Parameter | Subgroup 1 (EO-PE, n = 22) | Subgroup 2 (LO-PE, n = 94) | Sum of Squares | p Value | Subgroup 3 (Moderate PE, n = 88) | Subgroup 4 (Severe PE, n = 28) | Sum of Squares (SS) | p Value |
|---|---|---|---|---|---|---|---|---|
| MAP, MoM (mean ± SD) | 1.13 ± 0.08 | 1.09 ± 0.11 | 0.02 | 0.15 | 1.11 ± 0.10 | 1.07 ± 0.11 | 0.02 | 0.13 |
| UtA-PI, MoM (mean ± SD) | 1.52 ± 0.27 | 1.54 ± 0.29 | 0.01 | 0.61 | 1.56 ± 0.27 | 1.47 ± 0.34 | 0.17 | 0.16 |
| PAPP-A, MoM (mean ± SD) | 0.82 ± 0.24 | 0.83 ± 0.58 | 0.001 | 0.94 | 0.77 ± 0.21 | 0.81 ± 0.21 | 0.02 | 0.43 |
| PLGF, MoM (mean ± SD) | 1.18 ± 0.51 ** | 0.85 ± 0.32 | 1.97 | <0.001 | 0.86 ± 0.33 | 1.07 ± 0.47 ** | 1.04 | <0.001 |
| PP-13, MoM (mean ± SD) | 0.94± 0.48 ** | 0.72 ± 0.23 | 0.80 | 0.003 | 0.74 ± 0.30 | 0.83 ± 0.33 | 0.14 | 0.21 |
Table 3 legend: PE—preeclampsia; SD—standard deviation; MoM—multiples of median; MAP—mean arterial pressure; UtA-PI—uterine artery pulsatility index; PLGF—placental growth factor; PP-13—placental protein-13; PAPP-A—pregnancy-associated plasma protein-A; EO-PE—early-onset preeclampsia; LO-PE—late-onset preeclampsia. Tests used: ANOVA analysis with the Bonferroni post hoc test; ** the data from which statistical significance originates.